Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Assembly Biosciences(ASMB) the Revenue is 13.37 M (+38.94%), Beat estimate;the EBIT is -6.344 M (+42.81%), Beat estimate;the EPS is -0.2 (+84.96%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B38.94%
0.01B33.00%
+0.01B71.94%
EBITExceed expectations
-0.01B42.81%
-0.01B12.77%
+0.01B55.58%
EPSExceed expectations
-0.284.96%
-0.646751.38%
+0.446733.58%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf